SCHEMBL7201324

SCHEMBL7201324

Cc1cn([C@H]2C[C@H](O)[C@@H](C(O)OP(=O)(O)O)O2)c(=O)[nH]c1=O

nearest known ligand 0.66

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TK1 P04183 7/20 0.60
POLB P06746 1/20 0.56
TYMS P04818 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL932059 0.92 TK1 (0.58) TK1POLB
SCHEMBL25700727 0.89 TK1 (0.60) TK1POLBTYMS
SCHEMBL25756099 0.89 TK1 (0.60) TK1POLBTYMS
SCHEMBL25752637 0.89 TK1 (0.60) TK1POLBTYMS
SCHEMBL932058 0.88 TK1 (0.54) TK1POLB
SCHEMBL28537470 0.88 TK1 (0.67) TK1POLB
SCHEMBL7525577 0.88 TK1 (0.61) TK1POLBTYMS
SCHEMBL27984187 0.88 TK1 (0.61) TK1POLBTYMS
SCHEMBL6379327 0.86 TK1 (0.67) TK1
SCHEMBL933747 0.86 TK1 (0.59) TK1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240209008-A1 METHOD FOR PRODUCING ASYMMETRIC PHOSPHORIC ACID TRIESTER, METHOD FOR PRODUCING SYMMETRIC PHOSPHORIC ACID TRIESTER, METHOD FOR PRODUCING PHOSPHORIC ACID ESTER, AND METHOD FOR PRODUCING ORGANOPHOSPHORUS COMPOUND TOKYO INSTITUTE OF TECHNOLOGY (JP) 2024-06-27 US disclosed
EP-4303222-A1 METHOD FOR PRODUCING ASYMMETRIC PHOSPHORIC ACID TRIESTER, METHOD FOR PRODUCING SYMMETRIC PHOSPHORIC ACID TRIESTER, METHOD FOR PRODUCING PHOSPHORIC ACID ESTER, AND METHOD FOR PRODUCING ORGANOPHOSPHORUS COMPOUND Tokyo Institute of Technology (JP) 2024-01-10 EP disclosed
CN-116917301-A Method for producing asymmetric phosphotriester, method for producing symmetric phosphotriester, method for producing phosphate, and method for producing organic phosphorus compound 国立大学法人东京工业大学 2023-10-20 CN disclosed
WO-2022185843-A1 METHOD FOR PRODUCING ASYMMETRIC PHOSPHORIC ACID TRIESTER, METHOD FOR PRODUCING SYMMETRIC PHOSPHORIC ACID TRIESTER, METHOD FOR PRODUCING PHOSPHORIC ACID ESTER, AND METHOD FOR PRODUCING ORGANOPHOSPHORUS COMPOUND 国立大学法人東京工業大学 2022-09-09 WO disclosed
WO-2003040340-A9 NUCLEIC ACID AND CORRESPONDING PROTEIN ENTITLED 161P2F10B USEFUL IN TREATMENT AND DETECTION OF CANCER AGENSYS INC (US) 2003-08-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240209008-A1 METHOD FOR PRODUCING ASYMMETRIC PHOSPHORIC ACID TRIESTER, METHOD FOR PRODUCING SYMMETRIC PHOSPHORIC ACID TRIESTER, METHOD FOR PRODUCING PHOSPHORIC ACID ESTER, AND METHOD FOR PRODUCING ORGANOPHOSPHORUS COMPOUND HAO2, PLCB1, PHPT1 TK1 125/4885POLB 771/4885TYMS 547/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.